Catalogo dei prodotti della ricerca

COSTANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.833
EU - Europa 220
AS - Asia 157
AF - Africa 32
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.254
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.828
IN - India 64
IT - Italia 59
CN - Cina 46
SG - Singapore 40
DE - Germania 38
FI - Finlandia 33
TG - Togo 31
GB - Regno Unito 28
SE - Svezia 23
UA - Ucraina 17
AR - Argentina 11
BE - Belgio 5
RO - Romania 5
RU - Federazione Russa 5
CA - Canada 4
IE - Irlanda 4
KR - Corea 4
BG - Bulgaria 3
EU - Europa 1
IR - Iran 1
MN - Mongolia 1
MX - Messico 1
PK - Pakistan 1
SC - Seychelles 1
Totale 2.254
Salva come PNG Salva come JPEG
Città #
Fairfield 438
Woodbridge 194
Seattle 186
Ashburn 184
Cambridge 119
Houston 119
Wilmington 114
Chandler 56
Ann Arbor 42
Beijing 33
Princeton 33
Lawrence 32
Lomé 31
Plano 30
Millbury 27
Southend 24
Rome 22
San Diego 21
Dearborn 19
Singapore 18
Federal 11
San Paolo di Civitate 11
Andover 10
Jacksonville 10
Boston 8
Norwalk 7
Milan 6
Brussels 5
Dublin 4
Falls Church 4
Helsinki 4
Mannheim 4
Boardman 3
San Mateo 3
Sofia 3
Toronto 3
Turin 3
Bühl 2
Fremont 2
Hamburg 2
Hebei 2
Hefei 2
Jinan 2
Pune 2
Santa Maria Nuova 2
Bremen 1
Buffalo 1
Büdelsdorf 1
Chengdu 1
Chicago 1
Des Moines 1
Fuzhou 1
Gallarate 1
Indore 1
Islamabad 1
Jönköping 1
Kunming 1
London 1
Mumbai 1
Nanchang 1
Nanjing 1
New Bedfont 1
New York 1
Ottawa 1
Palermo 1
Provo 1
Redwood City 1
San Francisco 1
Tehran 1
Totale 1.881
Salva come PNG Salva come JPEG
Nome #
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. 93
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. 86
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 86
DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations. 82
HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. 82
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis 82
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. 81
Targeted therapy in nonmelanoma skin cancers. 81
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis 81
CD28 costimulation regulates FOXP3 in a RelA/NF-κB-dependent mechanism. 80
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris. 79
IL-21 in the pathogenesis and treatment of skin diseases. 79
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases. 79
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis. SUPREME study 79
The mechanistic basis for psoriasis immunopathogenesis: translating genotype to phenotype. Report of a workshop, Venice, 2012 78
Treatment of psoriasis and psoriatic arthritis. 77
Living Matter Observations with a Novel Hyperspectral Supercontinuum Confocal Microscope for VIS to Near-IR Reflectance Spectroscopy 77
Psoriasis: from pathogenesis to novel therapeutic approaches. 76
Functionalized gold nanoparticles for topical delivery of Methotrexate for the possible treatment of psoriasis 73
p63-dependent and independent mechanisms of nectin-1 and -4 regulation in the epidermis. 70
Infliximab in psoriasis and psoriatic arthritis. 70
Psoriatic arthritis and CARD15 gene polymorphisms. No evidence for association in the Italian population 68
IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia. 65
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy. 64
A symphony of regulations centered on p63 to control development of ectoderm-derived structures. 60
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. 60
null 54
Efalizumab. 51
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 51
Native/citrullinated LL37-specific T-cells help autoantibody production in systemic lupus erythematosus 49
Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-kappa B activation 38
Vav cooperates with CD28 to induce NF-kappa B activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1 30
Ustekinumab for treatment of plaque psoriasis in a patient with Down syndrome. 19
noveaux horizon therapeutiques pour le prurit dermatologique au delà de la dermatite atopique: role de i-modulia 9
Totale 2.289
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.098
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.098
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020764 94 35 4 40 85 91 111 93 98 44 46 23
2020/2021236 21 48 11 14 1 8 2 44 36 35 15 1
2021/2022389 1 24 49 16 38 2 9 53 30 28 72 67
2022/2023263 65 82 6 18 23 11 1 23 21 1 6 6
2023/2024111 5 19 7 14 6 6 1 1 1 19 14 18
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 2.289